Associations between Tissue Visfatin/Nicotinamide, Phosphoribosyltransferase (Nampt), Retinol Binding Protein-4, and Vaspin Concentrations and Insulin Resistance in Morbidly Obese Subjects

A Novel Adipocytokine, Visceral Adipose Tissue-derived Serine Protease Inhibitor (Vaspin), and Obesity

(2013) Q Li et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Relationship between vaspin gene expression and abdominal fat distribution of Korean women

(2011) Jin A Lee et al.   ENDOCRINE JOURNAL

Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism

(2011) G Á Martos-Moreno et al.   INTERNATIONAL JOURNAL OF OBESITY

Unknown

(2011) Michal Kukla et al.   MOLECULAR MEDICINE

The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes

(2010) Fusun Toruner et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China

(2010) Angela M. Thompson et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases

(2010) Carmela Rita Balistreri et al.   MEDIATORS OF INFLAMMATION

Inflammation, a Link between Obesity and Cardiovascular Disease

(2010) Zhaoxia Wang et al.   MEDIATORS OF INFLAMMATION

Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus

(2010) Hala O. El-Mesallamy et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Effects of Weight Reduction on Serum Vaspin Concentrations in Obese Subjects: Modification by Insulin Resistance

(2010) Hye M. Chang et al.   Obesity

Endoplasmic Reticulum Stress: Another Link Between Obesity and Insulin Resistance/Inflammation?

(2009) G. Boden   DIABETES

Adipocytokines and Insulin Resistance: The possible role of lipocalin-2, retinol binding protein-4, and adiponectin

(2009) E. Esteve et al.   DIABETES CARE

Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study

(2008) Ravi Retnakaran et al.   CLINICAL ENDOCRINOLOGY

Visfatin expression is not associated with adipose tissue abundance in the porcine model

(2008) Marie-France Palin et al.   DOMESTIC ANIMAL ENDOCRINOLOGY

The -1535 Promoter Variant of The Visfatin Gene Is Associated with Serum Triglyceride and HDL-cholesterol Levels in Japanese Subjects

(2008) Ayumi TOKUNAGA et al.   ENDOCRINE JOURNAL

Vaspin (SERPINA12) Genotypes and Risk of Type 2 Diabetes: Results from the MONICA/KORA studies

(2008) K. Kempf et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Vaspin: a novel serpin with insulin-sensitizing effects

(2008) Jun Wada   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Retinol-binding protein-4 in experimental and clinical metabolic disease

(2008) Maximilian von Eynatten et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Adipokines, Insulin Resistance, and Coronary Artery Calcification

(2008) Atif Qasim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY